This event-related functional MRI study examined the neural correlates for Chinese writing, by comparing the writing of logographic characters and that of pinyin, a phonetic notation system for Chinese characters. The temporal profile of the activations indicated that the middle frontal gyrus, superior parietal lobule, and posterior inferior temporal gyrus reflected more central processes for writing. Although pinyin writing elicited greater activity overall than character writing, the critical finding is that the two types of symbols recruited essentially the same brain regions. The results were compared with studies in Japanese showing dissociation between logographic kanji and phonetic kana writing and frequency of use was suggested to be an important factor in accounting for result differences across the two writing systems.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1097/WNR.0b013e3282f0405b | DOI Listing |
Sci Rep
December 2024
Department of Urology, The Jikei University School of Medicine, Kashiwa Hospital, Kashiwashita 163-1, Kashiwa, Chiba, 277-8567, Japan.
To evaluate the safety and efficacy of the Saroa Surgical Robot System in robot-assisted laparoscopic radical prostatectomy (RARP). We enrolled 60 patients who underwent RARP using either the Saroa (n = 9) or da Vinci Xi (n = 51) systems at Jikei University Kashiwa Hospital from January 2022 to March 2024. We compared preoperative characteristics, perioperative outcomes, complications, and postoperative urinary continence at three months between the two groups.
View Article and Find Full Text PDFSci Rep
December 2024
Department of Dermatology, Niazi Hospital, Lahore, Pakistan.
With breakthroughs in Natural Language Processing and Artificial Intelligence (AI), the usage of Large Language Models (LLMs) in academic research has increased tremendously. Models such as Generative Pre-trained Transformer (GPT) are used by researchers in literature review, abstract screening, and manuscript drafting. However, these models also present the attendant challenge of providing ethically questionable scientific information.
View Article and Find Full Text PDFAdv Mater
December 2024
Division of Materials Science and Engineering, Hanyang University, 222 Wangsimni-ro, Seongdong-gu, Seoul, 04763, Republic of Korea.
The development of efficient color conversion layers for μ-LED technology faces significant challenges owing to the limitations of materials that require binders. Binders are typically used to ensure uniform film formation in color-conversion layers, but they often cause optical losses, increase layer thickness, and introduce long-term stability issues. To address the limitations of materials requiring binders, cyclopropyltriphenylphosphonium manganese tetrabromide (CPTPMnBr) is synthesized, a novel lead-free metal halide.
View Article and Find Full Text PDFRev Sci Instrum
December 2024
MOE Key Laboratory of Fundamental Physical Quantities Measurement, Hubei Key Laboratory of Gravitation and Quantum Physics, PGMF and School of Physics, Huazhong University of Science and Technology, 1037 Luoyu Road, Wuhan 430074, People's Republic of China.
A compact and fast radio-frequency (RF) source developed for Raman sideband cooling (RSBC) in trapped ion and cold atom experiments is presented. The source is based on direct digital synthesizer, advanced real-time infrastructure for quantum physics, and field programmable gate array. The source has a frequency switching speed of 40 ns and can output continuous μs-level time sequences for RSBC.
View Article and Find Full Text PDFEClinicalMedicine
January 2025
Canadian Cancer Trials Group, Queen's University, Kingston, ON, Canada.
Background: Dual inhibition of cytotoxic T-lymphocyte associated protein 4 (CTLA-4) and programmed death ligand 1 (PD-L1) has been shown to be an effective treatment strategy in many cancers. We sought to determine the objective response rate of combination durvalumab (D) plus tremelimumab (TM) in parallel cohorts of patients with carefully selected rare cancer types in which these agents had not previously been evaluated in phase II trials and for which there was clinical or biological rationale for dual immune checkpoint inhibitor therapy to be active.
Methods: We designed a multi-centre, non-blinded, open-label phase II basket trial with each of the following 8 rare cancers considered a separate phase II trial: salivary carcinoma, carcinoma of unknown primary (CUP) with tumour infiltrating lymphocytes and/or expressing PD-L1, mucosal melanoma, acral melanoma, osteosarcoma, undifferentiated pleomorphic sarcoma, clear cell carcinoma of the ovary (CCCO) or squamous cell carcinoma of the anal canal (SCCA).
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!